Company to Participate in Upcoming Conferences WASHINGTON, April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may listen to a li ...

Shares of Evolent Health (EVH) have gained 9.4% over the past four weeks to close the last trading session at $33.75, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.38 indicates a potential upside of 34.5%.The mean estimate comprises 13 short-term price targets with a standard deviation of $7.37. While the lowest estimate of $34 indicates a 0.7% increase from the current pr ...

Shares of Evolent Health (EVH) have gained 10% over the past four weeks to close the last trading session at $33.53, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.50 indicates a potential upside of 35.7%.The mean estimate comprises 12 short-term price targets with a standard deviation of $7.80. While the lowest estimate of $34 indicates a 1.4% increase from the current pri ...

Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Conference Call February 22, 2024 5:00 PM ET Company Participants Seth Frank - Vice President of Investor Relations Seth Blackley - Chief Executive Officer, Co-Founder and Board Member John Johnson - Chief Financial Officer Conference Call Participants Andrea Alfonso - UBS Jailendra Singh - Truist Securities Jeff Garro - Stephens Anna Kruszenski - Barclays Ryan Daniels - William Blair Kyle Aikman - JPMorgan Jessica Tassan - Piper Sandler Charles Rhyee - TD Co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-37415 _________________________ Evolent Health, Inc. (Exact name of registrant as specified in its charter) _________________________ (State or other jurisdiction of incorporation or organization) Delaware 32-0454912 WASHINGTON, D.C. 20549 _________________________ FORM 10-K _________________________ (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December ...

WASHINGTON, Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a successful technology and health care executive who currently serves as Chief Executive Officer of Headspace, a pioneering company focused on digitally enabled mental hea ...

Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer, Co-Founder & Board Member John Johnson - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Kevin Caliendo - UBS Unknown speaker - Guggenheim Partners Charles Rhyee - TD Cowen Jeff Garro - Stephens Inc Richard Close - Canaccord Genuity David Larsen - BTIG Sean Dodge - RBC Capit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ Evolent Health, Inc. (Exact name of reg ...

| --- | --- | |-----------------------------|-------| | | | | | | | | | | | | | | | | Evolent | | | Second Quarter 2023 Results | | | | | | August 2, 2023 | | | CONTACT: | | | Seth R. Frank | | | Evolent Investor Relations | | | sfrank@evolent.com | | These statements are only predictions based on our current expectations and projections about future events. Forward-looking statements involve risks and uncertainties that may cause actual results, level of activity, performance or achievements to differ mate ...

Evolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Seth Frank – Vice President-Investor Relations Seth Blackley – Chief Executive Officer John Johnson – Chief Financial Officer Conference Call Participants Jeff Garro – Stephens Sean Dodge – RBC Capital Ryan Daniels – William Blair Charles Rhyee – TD Cowan David Larsen – BTIG Sandy Draper – Guggenheim Jessica Tassan – Piper Sandler Richard Close – Canaccord Genuity Jailendra Singh – Truist Operator ...